Synthesis of some new hydroxypyranone derivatives and evaluation of their anticonvulsant activities

Fabad Journal of Pharmaceutical Sciences

Volumn 31, Issue 1, 2006, Pages 23-29

  Aytemir, Mutlu Dilsiz ^a   Çaliş, Ünsal ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Allomaltol; Anticonvulsant activity; Hydroxypyranone derivatives; Kojic acid; Mannich reaction

Indexed keywords

2 (1,4' BIPIPERIDIN 1' YLMETHYL) 3 HYDROXY 6 METHYL 4H PYRAN 4 ONE; 2 (CHLOROMETHYL) 5 HYDROXY 4H PYRAN 4 ONE; 2 [[4 (2,3 DIMETHYLPHENYL)PIPERAZIN 1 YL]METHY] 3 HYDROXY 6 METHYL 4H PYRAN 4 ONE; 2 [[4 (3 CHLOROPHENYL)PIPERAZIN 1 YL]METHYL] 3 HYDROXY 6 METHYL 4H PYRAN 4 ONE; 3 HYDROXY 6 METHYL 2 (MORPHOLIN 4 YLMETHYL) 4H PYRAN 4 ONE; 3 HYDROXY 6 METHYL 2 [(4 PYRIMIDIN 2 YLPIPERAZIN 1 YL)METHYL] 4H PYRAN 4 ONE; 5 HYDROXY 2 METHYL 4H PYRAN 4 ONE; ANTICONVULSIVE AGENT; KOJIC ACID; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC SHOCK; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MANNICH REACTION; MOUSE; NEUROTOXICITY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE;

EID: 42549141801     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Malawska B. New anticonvulsant agents, Curr. Top. Med. Chem., 5(1), 69-85, 2005.
2. Shindikar AV, Khan F, Viswanathan CL. Design, synthesis and in vivo anticonvulsant screening in mice of novel phenylacetamides, Eur. J. Med. Chem., 41, 786-792, 2006.
3. Veverka M, Kralovicova E. Synthesis of some biologically active derivatives of 2-hydroxymethyl-5-hydroxy-4H-pyran-4-one, Collect. Czech. Chem. Commun., 55, 833-840, 1990.
4. Kayahara H, Shibata N, Tadasa K, Maeda H, Kotani T, Ichimoto I. Amino acid and peptide derivatives of kojic acid and their antifungal properties, Agr. Biol. Chem., 54(9), 2441-2442, 1990.
5. Kotani T, Ichimoto I, Tatsumi C, Fujita T. Structure-activity study of bacteriostatic kojic acid analogs, Agr. Biol. Chem., 39(6), 1311-1317, 1975.
6. Aytemir MD, Hider RC, Erol DD, Özalp M, Ekizoǧlu M. Synthesis of new antimicrobial agents; amide derivatives of pyranones and pyridinones, Turk J. Chem., 27(4), 445-452, 2003.
7. Aytemir MD, Erol DD, Hider RC, Özalp M. Synthesis and evaluation of antimicrobial activity of new 3-hydroxy-6-methyl-4-oxo-4H-pyran-2- carboxamide derivatives, Turk J. Chem., 27(6), 757-764, 2003.
8. Wan HM, Chen CC, Giridhar R, Chang TS, Wu WT. Repeated-batch production of kojic acid in a cell-retention fermenter using Aspergillus oryae M3B9, J. Ind. Microbiol. Biotechnol., 32(6), 227-233, 2005.
9. Veverka M. Synthesis of some biologically active derivatives of 2-hydroxymethyl-5-hydroxy-4H-pyran-4-one. II. Synthesis and biological properties of S-substituted 2-thiomethyl-5-O-acyl derivatives, Chem. Papers, 46(3), 206-210, 1992.
10. Uher M, Konecny V, Rajniakova O. Synthesis of 5-hydroxy-2-hydroxymethyl- 4H-pyran-4-one derivatives with pesticide activity, Chem. Papers, 48(4), 282-284, 1994.
11. Yamato M, Yasumoto Y, Sakai J, Luduena RF, Baneerjee A, Tashiro T. Synthesis and antitumor activity of tropolone derivatives. 6. Structure-activity relationships of antitumor-active tropolone and 8-hydroxyquinoline derivatives, J. Med. Chem., 30, 1897-1900, 1987.
12. Tamura T, Mitsumori K, Totsuka Y, Wakabayashi K, Kido R, Kasai H, Nasu M, Hirose M. Absence of in vivo genotoxic potential and tumor initiation activity of kojic acid in the rat thyroid, Toxicology, 222(3), 213-224, 2006.
13. Cabanes J, Chazarra S, Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase, J. Pharm. Pharmacol., 46, 982-985, 1994.
14. Kim H, Choi J, Cho JK, Kim SY, Lee YS. Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity, Bioorg. Med. Chem. Letters, 14, 2843-2846, 2004.
15. Moggia F, Brisset H, Fages F, Chaix C, Mandrand B, Dias M, Levillain E. Design, synthesis and redox properties of two ferrocene-containing iron chelators, Tetrahedron Letters, 47, 3371-3374, 2006.
16. Zborowski K, Grybos R, Proniewicz LM. Molecular structure of oxovanadium(IV) complexes with maltol and kojic acid: aquantum mechanical study, Inorg. Chem. Commun., 8, 76-78, 2005.
17. Finnegal MM, Lutz TG, Nelson WO, Smith A, Orvig C. Neutral water-soluble post-transition-metal chelate complexes of medical interest: aluminium and gallium tris(3-hydroxy-4-pyronates), Inorg. Chem., 26, 2171-2176, 1987.
18. Kimura R, Matsui S, Ito S, Aimoto T, Murata T. Central depressant effects of maltol analogs in mice, Chem. Pharm. Bull., 28, 2570-2579, 1980.
19. Aoyagi N, Kimura R, Murata T. Studies on Pasiflora incarnata dry extract. I. Isolation of maltol and pharmacological action of maltol and ethyl maltol, Chem. Pharm. Bull., 22(5), 1008-1013, 1974.
20. Korolkovas A. Antidepressants, Wiley J & Sons (eds), Essentials of Medicinal Chemistry Second Edition, New York, 307-328, 1988.
21. Aytemir MD, Çaliş Ü, Özalp M. Synthesis and evaluation of anticonvulsant and antimicrobial activities of 3-hydroxy-6-methyl-2-substituted 4H-pyran-4-one derivatives, Archiv Pharm. Pharm. Med. Chem., 337, 281-288, 2004.
22. Septioǧlu E, Aytemir MD, Çaliş Ü. Synthesis and anticonvulsant activity of some new hexahydropyrimidine-2,4-dione derivatives, Arzneim.-Forsch/Drug Res., 55(5), 259-264, 2005.
23. Özdemir Z, Kandilci BH, Gümüsel B, Çaliş Ü, Bilgin AA. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives, Eur. J. Med. Chem., 42, 373-379, 2007.
24. Krall RL, Penry JK, White BG, Kupferberg JH, Swinyard EA. Antiepileptic drug development: II. Anticonvulsant drug screening, Epilepsia, 9, 409-428, 1978.
25. Schäfer H. Chemical constitution and pharmacological effect, Frey HH, Janz D (eds), Handbook of Experimental Pharmacology-Antiepileptic Drugs, Springer-Verlag, Berlin, Chapter 9, 199-210, 1985.
26. Stables JP, Kupferberg HJ. The NIH anticonvulsant drug development (ADD) program: preclinical anticonvulsant screening project, Avanzini G, Tanganelli P, Avoli M (eds.), Molecular and Cellular Targets for Antiepileptic Drugs, John Libbey & Company Ltd, London, Chapter 16, 191-198, 1997.
27. 3+ values, Bioorg. Med. Chem., 9, 563-573, 2001.
28. Ellis BL, Duhme AK, Hider RC, Hossain MB, Rizvi S, van der Helm D. Synthesis, physicochemical properties, and biological evaluation of hydroxypyranone and hydroxypyridinones: novel bidentate ligands for cell-labeling, J. Med. Chem., 39, 3659-3670, 1996.
29. O'Brien G, Patterson JM, Meadow JR. Amino derivatives of kojic acid, J. Org. Chem., 25, 86-89, 1960.
30. Patel MK, Fox R, Taylor PD. Directed aminomethylation of 3-hydroxy-2(1H)-pyridinones and 3-hydroxy-4(1H)-pyridinones: synthesis of isodeferiprone, Tetrahedron, 52, 1835-1840, 1996.